Clinical Trials Logo

Clinical Trial Summary

This study will test the effectiveness of a new behavioral therapy for adults with trichotillomania (compulsive hair pulling).


Clinical Trial Description

Trichotillomania (TTM) is a disorder in which people compulsively pull out their own hair. Treatments for TTM sometimes do not have long-term effectiveness. Acceptance and commitment therapy (ACT) is a therapeutic approach thought to have longer lasting effects than standard cognitive behavioral therapy (CBT) approaches, because ACT focuses on accepting thoughts and behaviors as opposed to changing them. Previous research indicates that a combination of ACT and habit reversal behavioral therapy is more effective than no treatment. This study will test whether a combination of ACT and behavioral therapy, called acceptance enhanced behavioral therapy (AEBT), is more effective than the current standard treatment for TTM. Participation in this study will last 12 weeks, and follow-up assessments will last for 6 months. At study entry, participants will complete a brief intelligence test and an in-person interview about their medical history, psychiatric history, and hair pulling. At their second visit, participants will have digital pictures taken of their hair-pulling sites and complete two computer tasks measuring their response inhibition and cognitive flexibility. After the second visit, participants will be randomly assigned to receive either AEBT or psychoeducation and supportive therapy (PST)-a standard treatment for TTM. Both treatments will involve ten 1-hour sessions completed over 12 weeks. Assessments of participants will occur after 6 weeks of treatment, at treatment completion, and after 6 months. These assessments will measure treatment effectiveness, based on several clinical scales and measures of TTM symptoms. Participants who receive PST during this study will be offered AEBT afterward. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00872742
Study type Interventional
Source University of Wisconsin, Milwaukee
Contact
Status Completed
Phase Phase 2
Start date March 2009
Completion date November 30, 2015

See also
  Status Clinical Trial Phase
Completed NCT01445444 - Habit Reversal Training for Children and Adolescents With Trichotillomania N/A
Completed NCT04559750 - Internet CBT for Trichotillomania and Skin Picking Disorder N/A
Completed NCT01638975 - Response Inhibition Training for Individuals With Trichotillomania N/A
Completed NCT00993265 - N-Acetylcysteine for Pediatric Trichotillomania Phase 2
Completed NCT00917098 - Examining Behavior Therapy for Trichotillomania in Children and Adolescents N/A
Recruiting NCT00552266 - Methylphenidate in ADHD With Trichotillomania Phase 4
Completed NCT03530800 - Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors Phase 2/Phase 3
Completed NCT01984333 - Online Response Inhibition Training for Trichotillomania N/A
Completed NCT00740909 - Cognitive Behavioral Therapy for Trichotillomania Phase 1/Phase 2
Recruiting NCT05003401 - Leveraging Technological Advancements to Improve the Treatment of Trichotillomania N/A
Completed NCT01875445 - Inositol in Trichotillomania Phase 2
Completed NCT03486041 - Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania N/A
Completed NCT02473913 - Milk Thistle in Trichotillomania in Children and Adults Phase 2
Completed NCT00182507 - Olanzapine in the Treatment of Hair Pulling (Trichotillomania) Phase 4
Completed NCT00947154 - Trial of Aripiprazole in Trichotillomania N/A
Completed NCT00354770 - N-Acetyl Cysteine in Trichotillomania Phase 2
Completed NCT00004550 - Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions N/A
Completed NCT01878110 - Efficacy of COMB (Comprehensive Behavioral) Model of Treatment of Trichotillomania N/A
Active, not recruiting NCT01075672 - Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals N/A
Completed NCT01968343 - Trichotillomania: Group Cognitive-Behavioral Therapy Phase 2